Marker Therapeutics Inc
MRKR
$1.21-0.05 (-3.97%)
Aug 18, 2025, 4:00 PM
Financials
| 52Week High | 5.95 | 52Week Low | 0.95 |
| Beta | 1.49 | Current Ratio Annual | 6.36 |
| Current Ratio Quarterly | 6.79 | Market Cap | 15.66M |
| Net Profit Margin TTM | -224.45 | Operating Margin TTM | -231.35 |
| Price To Book | 1.08 | Price To Sales TTM | 2.75 |
| Quick Ratio Annual | 6.22 | Quick Ratio Quarterly | 6.46 |
| Return On Assets TTM | -83.02 | Return On Equity TTM | -101.86 |
| Return On Investment TTM | -101.86 | Revenue Growth3Y | 74.52 |
| Revenue Growth5Y | 99.23 | Revenue Growth Quarterly Yoy | -71.94 |
| Revenue Growth TTMYoy | 71.54 | Revenue Per Share TTM | 0.51 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 34 | 1 | 1 | 1 | 1 | 1 | 4.47M | $49.25M |
| Mar 31, 2025 | 33(-3%) | 3(+200%) | 3(+200%) | 10(+900%) | 6(+500%) | 13(+1200%) | 4.10M(-8%) | $4.95M(-90%) |
| Jun 30, 2025 | 30(-9%) | 2(-33%) | 4(+33%) | 5(-50%) | 7(+17%) | 14(+8%) | 3.38M(-18%) | $5.18M(+5%) |